Personalis IncEquity-NMS: PSNL
Equity-NMS: PSNL
$1.5
+0.22
(9:00 pm IST)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$1.50
Open
$1.50
Today’s high
$1.52
Today’s low
$1.30
52W low
$0.89
52W high
$3.27
1Y
-50.33%
PE
-0.56
EPS (TTM)
-2.38
Shares O/S
49.03M
Market cap
73.55M
Insights
PSNL price is below its 200 day moving average
PSNL is in the lowest 10% returns in the past year. It is a low momentum stock. Low momentum stocks tend to underperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Personalis Inc

Personalis, Inc. is a cancer genomics company, which is engaged in providing precision cancer therapies and diagnostics. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other next generation cancer immunotherapies. The NeXT platform is a next generation sequencing and analysis platform.

The NeXT platform is designed to provide comprehensive analysis of both a tumor and its immune microenvironment from a single limited tissue or plasma sample. Its products are designed to detect recurrence at the earliest timepoints, enable selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Its research-focused products include exome sequencing, transcriptome sequencing, and targeted cancer panels. The Company’s platform analyses elements of the immune cells that have infiltrated a tumor both from the adaptive immune system and the innate immune system. .


FAQs

Can I buy Personalis Inc shares in India?
How to buy Personalis Inc shares in India?
What is the share price of Personalis Inc?
What is the Market Capitalization of Personalis Inc?
What is the PE ratio of Personalis Inc?
Is Personalis Inc a good stock to buy?
In which sector / industry does Personalis Inc operate?